Literature DB >> 2834625

Immunity to varicella zoster virus in children with leukaemia.

P M Ndumbe1, K Wheeler, J M Chessells, R J Levinsky.   

Abstract

A total of 46% (32/70) of children with acute lymphoblastic leukaemia presenting to the Hospital for Sick Children had a past history of chickenpox. When their immunity to varicella zoster virus (VZV) was assessed, 75% (24/32) had a positive lymphocyte transformation response to VZV antigen in tissue culture while 78% (25/32) possessed IgG antibody against VZV. Therefore, at least 22% of the children were probably susceptible to infection with VZV inspite of having a history suggestive of chickenpox. Of those with a negative or uncertain history 34% had a positive lymphocyte transformation response, while 55% (21/38) had IgG antibody against VZV. Therefore, about one in two of those with a negative history to VZV had some form of immunity to VZV. Hence, regardless of their VZV infection history, children with leukaemia would need to undergo both cell mediated and humoral immunity tests before they may be considered for immunisation with the live varicella vaccine. From our studies, 34% (24/70) of our patients did not have any evidence of immunity to VZV by either test method. These would be considered for immunisation with the live varicella vaccine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834625     DOI: 10.1007/BF00189529

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

1.  NIH conference. Herpes zoster-varicella infections in immunosuppressed patients.

Authors:  R Dolin; R C Reichman; M H Mazur; R J Whitley
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

2.  Immunity to varicella-zoster virus in a normal adult population.

Authors:  P M Ndumbe; S Macqueen; H Holzel; R J Levinsky
Journal:  J Med Microbiol       Date:  1985-08       Impact factor: 2.472

3.  Prevention of varicella by zoster immune globulin.

Authors:  P A Brunell; A Ross; L H Miller; B Kuo
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

4.  Immunologic evidence of reinfection with varicella-zoster virus.

Authors:  G H Talbot; M Skros; M Fisher; H Friedman
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

5.  Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine.

Authors:  R Berger; D Luescher; M Just
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

6.  Life-threatening complications of varicella.

Authors:  G Fleisher; W Henry; M McSorley; A Arbeter; S Plotkin
Journal:  Am J Dis Child       Date:  1981-10

7.  Studies on the immune status of children with acute lymphocytic leukaemia. II. In remission with and without cytostatic treatment.

Authors:  W H Hitzig; H J Plüss; P Joller; U Pilgrim; H Tacier-Eugster; M Jakob
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  Varicella in children with cancer: Seventy-seven cases.

Authors:  S Feldman; W T Hughes; C B Daniel
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

9.  Administration of live varicella vaccine to children wtih leukaemia.

Authors:  P A Brunell; Z Shehab; C Geiser; J E Waugh
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

10.  Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukaemia.

Authors:  L Layward; R J Levinsky; M Butler
Journal:  Br J Haematol       Date:  1981-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.